Phenominer Database Results (20 results)

 
 
How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Formula Value Units SEM SD Method Method Duration Post Insult Time Value Method Notes Record ID Study ID
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 3 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103820 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 1.72 null 0.3 0.59 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103828 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 2.04 null 0.21 0.42 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103831 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 (fasting glucose x fasting insulin)/22.5 8.2 null 1.35 2.7 oral glucose tolerance test 7200.0 103838 2864
GK/MolTac plasma insulin level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 27.3 mU/l 4.16 8.32 oral glucose tolerance test 0.0 103817 2864
GK/MolTac blood glucose level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 95.0 days-102.0 days 4 142.0 mg/dl 4.0 8.0 oral glucose tolerance test 0.0 103807 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103821 2864
GK/MolTac plasma insulin level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 38.22 mU/l 5.2 10.4 oral glucose tolerance test 0.0 103816 2864
GK/MolTac blood glucose level rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 122.0 days-129.0 days 4 145.0 mg/dl 7.5 15.0 oral glucose tolerance test 0.0 103810 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103823 2864
GK/MolTac blood insulin level AUC to blood glucose level AUC ratio rosiglitazone (10 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 AUC ins/glu 0.0 null 0.0 0.0 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103824 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 3 10,000/√(FG x FI) x (Ḡ x Ī) 1.73 null 0.2 0.34 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103827 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 (fasting glucose x fasting insulin)/22.5 14.2 null 2.15 4.3 oral glucose tolerance test 7200.0 103837 2864
GK/MolTac blood glucose level rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 122.0 days-129.0 days 4 177.0 mg/dl 5.5 11.0 oral glucose tolerance test 0.0 103809 2864
GK/MolTac plasma insulin level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 3 30.42 mU/l 4.2 7.28 oral glucose tolerance test 0.0 103813 2864
GK/MolTac blood glucose level rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 16 hours) then glucose solution (2 g/kg) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood glucose amount male 95.0 days-102.0 days 3 146.0 mg/dl 3.46 6.0 oral glucose tolerance test 0.0 103806 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (5 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 3 (fasting glucose x fasting insulin)/22.5 9.8 null 1.21 2.1 oral glucose tolerance test 7200.0 103834 2864
GK/MolTac whole body insulin sensitivity index rosiglitazone (5 mg/kg) (for 23 days) then control condition (for 20 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 122.0 days-129.0 days 4 10,000/√(FG x FI) x (Ḡ x Ī) 1.27 null 0.23 0.46 oral glucose tolerance test 7200.0 measured at -5,15,30,45,60,90,120 min 103830 2864
GK/MolTac Homeostatic Model Assessment of Insulin Resistance rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 4 (fasting glucose x fasting insulin)/22.5 10.2 null 1.35 2.7 oral glucose tolerance test 7200.0 103835 2864
GK/MolTac plasma insulin level rosiglitazone (10 mg/kg) (for 23 days) then fasting (for 12 hours) Gao W and Jusko WJ, J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29. blood insulin amount male 95.0 days-102.0 days 4 34.58 mU/l 4.68 9.36 oral glucose tolerance test 0.0 103814 2864